News & Events
Combinostics and SyntheticMR to join forces
Combinostics today announced that it has entered an agreement with the Swedish company SyntheticMR where SyntheticMR, subject to approval by an Extraordinary General Meeting, will acquire all shares in Combinostics.
Combinostics cNeuro cDAT application for quantification of DAT SPECT images released in Europe
New cDAT application for for automated quantification of DAT SPECT images further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows
RSNA 2023
Attending RSNA 2022? Stop by booth 3938 in the AI Showcase to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
Combinostics new PET quantification application cNeuro cPET receives FDA 510(k) clearance
New cPET application for amyloid and FDG brain PET quantification further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows.
Combinostics New PET Quantification application cNeuro cPET released in Europe
New cPET application for amyloid and FDG brain PET quantification further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows
AAIC 2023
Attending ASNR 2023? Stop by booth 603 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
SNMMI 2023
Attending ASNR 2023? Stop by booth 603 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
Revolutionising Precision Medicine: PROMINENT Project will Enhance Diagnosis and Treatment of Neurodegenerative Diseases, Improving Patients’ Lives Across Europe
Stockholm, 14 June 2023 – Today, partners of the PROMINENT project announced the
104th German X-ray Congress
Visit us at booth Süd 36 at the 104th German X-ray Congress (RÖKO2023) to learn more about our complete solution for the early detection, diagnosis, and management of neurological disorders.
